Shorts

0:46
Combining CELMoDs and Cell Therapies in Myeloma
6 months ago
by
Sagar Lonial, MD, FACP

0:49
Balancing Therapy and QOL With MRD Testing in Gastroesophageal Cancer
6 months ago
by
Rutika Mehta, MD, MPH

0:35
A Mass in the Right-Sided Kidney
6 months ago
by
Pavlos Msaouel, MD, PhD

0:47
Menin Inhibitors Could Redefine AML Frontline Therapy
6 months ago
by
Richard Stone, MD

0:42
Setting a New Standard in EGFR+ Lung Cancer
6 months ago
by
Nicolas Girard, MD, PhD

0:46
Survival With Bispecific Combo Favors Early Use in Myeloma
6 months ago
by
Roberto Mina, MD

0:33
The Key Test to Confirm RMC Diagnosis is Immunohistochemistry for INI1
6 months ago
by
Pavlos Msaouel, MD, PhD

0:48
The Need for HRR Mutation Testing in Prostate Cancer
6 months ago
by
Sandy Srinivas, MD

1:27
Are We Nearing the End of 7+3 Alone in AML?
6 months ago
by
Richard Stone, MD

0:32
One Analogy Doesn't Work for Every Patient
6 months ago
by
Sanjay K. Juneja, MD(+1 more)

0:34
Managing Toxicities in Patients on Erdafitinib Therapy
6 months ago
by
Thomas W. Flaig, MD

0:59
The Power of a Gut Feeling in Cancer Care
6 months ago
by
Sanjay K. Juneja, MD

0:38
New Frontiers in Urothelial Carcinoma
6 months ago
by
Thomas W. Flaig, MD

0:32
CLL17 3-Year Update: Who May Benefit From Continuous Therapy?
6 months ago
by
Nicole Lamanna, MD

1:00
Bringing Clinical Trials Into the Community
6 months ago
by
Danny Nguyen, MD

0:43
Early-Onset CRC: Thinking Beyond the Tumor
6 months ago
by
Patrick Boland, MD

0:46
How AI is Revolutionizing Clinical Trials
6 months ago
by
Danny Nguyen, MD

0:57
Why Clinical Trials Aren't Just a Last Resort for Cancer
6 months ago
by
Danny Nguyen, MD

0:55
Big Shifts Ahead in Lung Cancer: New KRAS Data and Paradigm Changes
7 months ago
by
Christine Bestvina, MD

0:28
Decentralized Clinical Trials: Reducing the Logistical Burden of Participation
7 months ago
by
Inna Gong, MD, PhD

1:18
Why Women Face Longer Delays in Lung Cancer Diagnosis
7 months ago
by
Narjust Florez, MD

0:57
A “Cancer Genome Atlas” for Immune Profiles?
7 months ago
by
Won Jin Ho, MD

0:32
Confronting Feelings of Guilt in Younger Patients
7 months ago
by
Narjust Florez, MD

0:51
Why Young Women's Lung Cancer Symptoms Are Often Ignored
7 months ago
by
Narjust Florez, MD

1:07
Why ZIP Code Shouldn't Determine Cancer Outcomes
7 months ago
by
Pallav K. Mehta, MD(+1 more)

0:52
Guideline Updates in Lymphoma Treatment
7 months ago
by
Hua-Jay "Jeff" Cherng, MD

0:31
Why You Shouldn't Wait to Treat MDS
7 months ago
by
David Sallman, MD

0:32
My Strategy for MDS Patients Waiting Transplant
7 months ago
by
David Sallman, MD

0:50
Why Haven't Trial Participation Rates Improved?
7 months ago
by
Inna Gong, MD, PhD

0:55
Combating Misinformation: The Truth About the HPV Vaccine
7 months ago
by
Natalie Berger, MD
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Breakthrough Status to Multi-Cancer Early Detection Blood Test
2
FDA Clears Phase 2 Trial of B7-H3 CAR T MT027 for Brain Metastases
3
As New TGCT Therapies Advance, Route, Duration, and Coverage Shape CSF1R Inhibitor Choice
4
Alpha-Emitting RYZ101 Meets Phase 3 PFS End Point in Advanced GEP-NETs
5
